Weidong Zhao

Dec 10, 2024 | mdpi.com | Ting Chen |Weidong Zhao |Bo Lin |Yangxin Xiong

1. IntroductionWith the economic growth, urbanization development, and significant improvement in living standards in recent years, the number of motor vehicles in Chengdu has been increasing every year, with Chengdu becoming the number one city in China in 2023. The Sichuan Basin, to which Chengdu belongs, has a unique topography with a relatively low terrain.

Nov 28, 2024 | onlinelibrary.wiley.com | Zongyu Liu |Hongyu Chu |Weidong Zhao |Chenguang Yang

1 Introduction Opdivo (nivolumab) plus Yervoy (ipilimumab) is dual immunotherapy targeting and blocking the immune checkpoints PD1 and CTLA-4, and has been successfully applied in clinical cancer therapy,[1] including colorectal cancer,[2] hepatocellular carcinoma,[3] and non-small cell carcinoma.[4] Less than 30% of cancer patients respond to immune checkpoint therapy, but treatment with Opdivo plus Yervoy at an optimum dosage ratio of 3:1 enhances antitumor efficacy.

Jan 16, 2024 | esaim-m2an.org | Weidong Zhao |Wenju Zhao

ESAIM: M2AN 58 (2024) 23–46A generalized finite element θ-scheme for backward stochastic partial differential equations and its error estimates, and *School of Mathematics, Shandong University Jinan, Shandong 250100, P.R. China * Corresponding author: [email protected]: 1 August 2023Accepted: 5 December 2023AbstractIn this paper, we study numerical methods for solving a class of nonlinear backward stochastic partial differential equations.